newratings.com  Dec 5  Comment 
SAINT HELIER (dpa-AFX) - Alnylam Pharmaceuticals Inc. (ALNY), on Sunday, reported positive interim clinical results of its investigational RNAi therapeutic Fitusiran from an ongoing phase II open label extension study in patients with Hemophilia A...
Reuters  Dec 2  Comment 
* Teleflex - In connection with termination of merger agreement, Vascular Solutions may be required to pay Teleflex a termination fee of $35 million Source text: [http://bit.ly/2gRnRQC] Further...
newratings.com  Dec 2  Comment 
OTTAWA (dpa-AFX) - Teleflex Inc. (TFX) and Vascular Solutions Inc. (VASC) announced that they have entered into a definitive agreement by which Teleflex will acquire Vascular Solutions in a transaction valued at approximately $1.0 billion. As per...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki